Isoliquiritigenin Induces Caspase-Dependent Apoptosis via Downregulation of HPV16 E6 Expression in Cervical Cancer Ca Ski Cells

Planta Medica

Volumn 79, Issue 17, 2013, Pages 1628-1635

  Hirchaud, Fabienne ^a,b   Hermetet, François ^a,b   Ablise, Mourboul ^d   Fauconnet, Sylvie ^a,b,c   Vuitton, Dominique A ^a,b   Prétet, Jean Luc ^a,b,c   Mougin, Christiane ^a,b,c  

^a UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^b LabEx LipSTIC ANR 11 LABX 0021 ^*  (France)

^c UNIVERSITY HOSPITAL OF BESANÇON   (France)

^d XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

apoptosis; cervix carcinoma; Glycyrrhiza inflata; HPV16 E6; isoliquiritigenin; Leguminosae

Indexed keywords

CASPASE; CASPASE 3; CASPASE 8; CASPASE 9; CYTOCHROME C; ISOLIQUIRITIGENIN; PROTEIN P21; PROTEIN P53;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER PREVENTION; CANCER THERAPY; CELL VIABILITY; CONTROLLED STUDY; CYTOSOL; FEMALE; GENE EXPRESSION; HELA CELL; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; MITOCHONDRIAL MEMBRANE POTENTIAL; UTERINE CERVIX CANCER;

FABACEAE; GLYCYRRHIZA; GLYCYRRHIZA INFLATA;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; CASPASE INHIBITORS; CASPASES; CELL LINE, TUMOR; CHALCONES; CYTOCHROMES C; DOWN-REGULATION; DRUGS, CHINESE HERBAL; FEMALE; GLYCYRRHIZA; HELA CELLS; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; ONCOGENE PROTEINS, VIRAL; PHYTOTHERAPY; PROTO-ONCOGENE PROTEINS C-BCL-2; REPRESSOR PROTEINS; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS;

EID: 84889595124     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0033-1350956     Document Type: Article

References (59)

1. Ferlay J., Shin H. R., Bray F., Forman D., Mathers C., Parkin D. M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer: 2010; 127 2893 2917
2. Muñoz N., Bosch F. X., de Sanjosé S., Herrero R., Castellsagué X., Shah K. V., Snijders P. JF, Meijer C. JLM. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med: 2003; 348 518 527 (Pubitemid 36159887)
3. Garland S. M. Human papillomavirus update with a particular focus on cervical disease. Pathology: 2002; 34 213 224 (Pubitemid 34628180)
4. Prétet J. L., Jacquard A. C., Carcopino X., Charlot J. F., Bouhour D., Kantelip B., Soubeyrand B., Leocmach Y., Mougin C., Riethmuller D. Human papillomavirus (HPV) genotype distribution in invasive cervical cancers in France: EDITH study. Int J Cancer: 2008; 122 428 432 (Pubitemid 350234732)
5. Da Rocha A. B., Lopes R. M., Schwartsmann G. Natural products in anticancer therapy. Curr Opin Pharmacol: 2001; 1 364 369 (Pubitemid 33585985)
6. Vaya J., Belinky P. A., Aviram M. Antioxidant constituents from licorice roots: isolation, structure elucidation and antioxidative capacity toward LDL oxidation. Free Radic Biol Med: 1997; 23 302 313 (Pubitemid 27276611)
7. Chan S. C., Chang Y. S., Wang J. P., Chen S. C., Kuo S. C. Three new flavonoids and antiallergic, anti-inflammatory constituents from the heartwood of Dalbergia odorifera. Planta Med: 1998; 64 153 158
8. Tawata M., Aida K., Noguchi T., Ozaki Y., Kume S., Sasaki H., Chin M., Onaya T. Anti-platelet action of isoliquiritigenin, an aldose reductase inhibitor in licorice. Eur J Pharmacol: 1992; 212 87 92
9. Maggiolini M., Statti G., Vivacqua A., Gabriele S., Rago V., Loizzo M., Menichini F., Amdò S. Estrogenic and antiproliferative activities of isoliquiritigenin in MCF7 breast cancer cells. J Steroid Biochem Mol Biol: 2002; 82 315 322 (Pubitemid 36187399)
10. Hsu Y. L., Kuo P. L., Lin C. C. Isoliquiritigenin induces apoptosis and cell cycle arrest through p 53-dependent pathway in Hep G2 cells. Life Sci: 2005; 77 279 292
11. Jung J. I., Lim S. S., Choi H. J., Cho H. J., Shin H. K., Kim E. J., Chung W. Y., Park K. K., Park J. HY. Isoliquiritigenin induces apoptosis by depolarizing mitochondrial membranes in prostate cancer cells. J Nutr Biochem: 2006; 17 689 696 (Pubitemid 44380373)
12. Hsu Y. L., Kuo P. L., Chiang L. C., Lin C. C. Isoliquiritigenin inhibits the proliferation and induces the apoptosis of human non-small cell lung cancer a549 cells. Clin Exp Pharmacol Physiol: 2004; 31 414 418
13. Kwon G. T., Cho H. J., Chung W. Y., Park K. K., Moon A., Park J. HY. Isoliquiritigenin inhibits migration and invasion of prostate cancer cells: possible mediation by decreased JNK/AP-1 signaling. J Nutr Biochem: 2009; 20 663 676
14. Ii T., Satomi Y., Katoh D., Shimada J., Baba M., Okuyama T., Nishino H., Kitamura N. Induction of cell cycle arrest and p 21(CIP1/ WAF1) expression in human lung cancer cells by isoliquiritigenin. Cancer Lett: 2004; 207 27 35 (Pubitemid 38429884)
15. Iwashita K., Kobori M., Yamaki K., Tsushida T. Flavonoids inhibit cell growth and induce apoptosis in B16 melanoma 4A5 cells. Biosci Biotechnol Biochem: 2000; 64 1813 1820
16. Zhou G. S., Song L. J., Yang B. Isoliquiritigenin inhibits proliferation and induces apoptosis of U87 human glioma cells in vitro. Mol Med Rep: 2013; 7 531 536
17. Chen X., Wu Y., Jiang Y., Zhou Y., Wang Y., Yao Y., Yi C., Gou L., Yang J. Isoliquiritigenin inhibits the growth of multiple myeloma via blocking IL-6 signaling. J Mol Med: 2012; 90 1311 1319
18. Kim D., Ramachandran S., Baek S., Kwon S. H., Kwon K. Y., Cha S. D., Bae I., Cho C. H. Induction of growth inhibition and apoptosis in human uterine leiomyoma cells by isoliquiritigenin. Reprod Sci: 2008; 15 552 558 (Pubitemid 351875956)
19. Auyeung K. KW, Ko J. KS. Novel herbal flavonoids promote apoptosis but differentially induce cell cycle arrest in human colon cancer cell. Invest New Drugs: 2010; 28 1 13 (Pubitemid 46274648)
20. Hsu Y. L., Chia C. C., Chen P. J., Huang S. E., Huang S. C., Kuo P. L. Shallot and licorice constituent isoliquiritigenin arrests cell cycle progression and induces apoptosis through the induction of ATM/ p 53 and initiation of the mitochondrial system in human cervical carcinoma HeLa cells. Mol Nutr Food Res: 2009; 53 826 835
21. Yuan X., Zhang B., Gan L., Wang Z. H., Yu B. C., Liu L. L., Zheng Q. S., Wang Z. P. Involvement of the mitochondrion-dependent and the endoplasmic reticulum stress-signaling pathways in isoliquiritigenin-induced apoptosis of HeLa cell. Biomed Environ Sci: 2013; 26 268 276
22. Zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer: 2002; 2 342 350 (Pubitemid 37328947)
23. Scheffner M., Huibregtse J. M., Vierstra R. D., Howley P. M. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p 53. Cell: 1993; 75 495 505 (Pubitemid 23335075)
24. Filippova M., Song H., Connolly J. L., Dermody T. S., Duerksen-Hughes P. J. The human papillomavirus 16 E6 protein binds to tumor necrosis factor (TNF) R1 and protects cells from TNF-induced apoptosis. J Biol Chem: 2002; 277 21730 21739 (Pubitemid 34952324)
25. Filippova M., Parkhurst L., Duerksen-Hughes P. J. The human papillomavirus 16 E6 protein binds to Fas-associated death domain and protects cells from Fas-triggered apoptosis. J Biol Chem: 2004; 279 25729 25744 (Pubitemid 38756837)
26. Goodwin E. C., DiMaio D. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways. Proc Natl Acad Sci U S A: 2000; 97 12513 12518
27. Vogt M., Butz K., Dymalla S., Semzow J., Hoppe-Seyler F. Inhibition of Bax activity is crucial for the antiapoptotic function of the human papillomavirus E6 oncoprotein. Oncogene: 2006; 25 4009 4015 (Pubitemid 44024863)
28. Hamada K., Sakaue M., Alemany R., Zhang W. W., Horio Y., Roth J. A., Mitchell M. F. Adenovirus-mediated transfer of HPV 16 E6/E7 antisense RNA to human cervical cancer cells. Gynecol Oncol: 1996; 63 219 227 (Pubitemid 26398603)
29. Pattillo R. A., Hussa R. O., Story M. T., Ruckert A. C., Shalaby M. R., Mattingly R. F. Tumor antigen and human chorionic gonadotropin in CaSki cells: a new epidermoid cervical cancer cell line. Science: 1977; 196 1456 1458 (Pubitemid 8122337)
30. Walboomers J. M., Jacobs M. V., Manos M. M., Bosch F. X., Kummer J. A., Shah K. V., Snijders P. J., Peto J., Meijer C. J., Muñoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol: 1999; 189 12 19 (Pubitemid 29406813)
31. Bernard B., Fest T., Prétet J. L., Mougin C. Staurosporine-induced apoptosis of HPV positive and negative human cervical cancer cells from different points in the cell cycle. Cell Death Differ: 2001; 8 234 244 (Pubitemid 32288169)
32. Bernard B., Prétet J. L., Charlot J. F., Mougin C. Human papillomaviruses type 16+ and 18+ cervical carcinoma cells are sensitive to staurosporine-mediated apoptosis. Biol Cell: 2003; 95 17 26 (Pubitemid 36621833)
33. Charlot J. F., Prétet J. L., Haughey C., Mougin C. Mitochondrial translocation of p 53 and mitochondrial membrane potential (Delta Psi m) dissipation are early events in staurosporine-induced apoptosis of wild type and mutated p 53 epithelial cells. Apoptosis: 2004; 9 333 343 (Pubitemid 38981507)
34. Charlot J. F., Nicolier M., Prétet J. L., Mougin C. Modulation of p 53 transcriptional activity by PRIMA-1 and Pifithrin-alpha on staurosporine-induced apoptosis of wild-type and mutated p 53 epithelial cells. Apoptosis: 2006; 11 813 827 (Pubitemid 43876850)
35. Nicolier M., Decrion-Barthod A. Z., Launay S., Prétet J. L., Mougin C. Spatiotemporal activation of caspase-dependent and -independent pathways in staurosporine-induced apoptosis of p 53 wt and p 53 mt human cervical carcinoma cells. Biol Cell: 2009; 101 455 467
36. Kroemer G., El-Deiry W. S., Golstein P., Peter M. E., Vaux D., Vandenabeele P., Zhivotovsky B., Blagosklonny M. V., Malorni W., Knight R. A., Piacentini M., Nagata S., Melino G. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death. Cell Death Differ: 2005; 12 02 1463 1467 (Pubitemid 41553979)
37. Fulda S., Debatin K. M. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene: 2006; 25 4798 4811 (Pubitemid 44187627)
38. Kroemer G., Galluzzi L., Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol Rev: 2007; 87 99 163 (Pubitemid 46209992)
39. Vousden K. H., Lu X. Live or let die: the cellÊs response to p 53. Nat Rev Cancer: 2002; 2 594 604 (Pubitemid 37328926)
40. Ohtsuka T., Ryu H., Minamishima Y. A., Macip S., Sagara J., Nakayama K. I., Aaronson S. A., Lee S. W. ASC is a Bax adaptor and regulates the p 53-Bax mitochondrial apoptosis pathway. Nat Cell Biol: 2004; 6 121 128 (Pubitemid 38425711)
41. Wu Y., Mehew J. W., Heckman C. A., Arcinas M., Boxer L. M. Negative regulation of bcl-2 expression by p 53 in hematopoietic cells. Oncogene: 2001; 20 240 251 (Pubitemid 32150269)
42. Tomita Y., Marchenko N., Erster S., Nemajerova A., Dehner A., Klein C., Pan H., Kessler H., Pancoska P., Moll U. M. WT p 53, but not tumor-derived mutants, bind to Bcl2 via the DNA binding domain and induce mitochondrial permeabilization. J Biol Chem: 2006; 281 8600 8606 (Pubitemid 43847963)
43. Leu J. I., Dumont P., Hafey M., Murphy M. E., George D. L. Mitochondrial p 53 activates Bak and causes disruption of a Bak-Mcl1 complex. Nat Cell Biol: 2004; 6 443 450 (Pubitemid 38607505)
44. Mihara M., Erster S., Zaika A., Petrenko O., Chittenden T., Pancoska P., Moll U. M. p 53 has a direct apoptogenic role at the mitochondria. Mol Cell: 2003; 11 577 590 (Pubitemid 36385115)
45. Garnett T. O., Filippova M., Duerksen-Hughes P. J. Accelerated degradation of FADD and procaspase 8 in cells expressing human papilloma virus 16 E6 impairs TRAIL-mediated apoptosis. Cell Death Differ: 2006; 13 1915 1926 (Pubitemid 44542404)
46. Bennett M., Macdonald K., Chan S. W., Luzio J. P., Simari R., Weissberg P. Cell surface trafficking of Fas: a rapid mechanism of p  53-mediated apoptosis. Science: 1998; 282 290 293 (Pubitemid 28487200)
47. Jong J. E., Jeong K. W., Shin H., Hwang L. R., Lee D., Seo T. Human papillomavirus type 16 E6 protein inhibits DNA fragmentation via interaction with DNA fragmentation factor 40. Cancer Lett: 2012; 324 109 117
48. Kalantari M., Calleja-Macias I. E., Tewari D., Hagmar B., Lie K., Barrera-Saldana H. A., Wiley D. J., Bernard H. U. Conserved methylation patterns of human papillomavirus type 16 DNA in asymptomatic infection and cervical neoplasia. J Virol: 2004; 78 12762 12772 (Pubitemid 39507784)
49. Bhattacharjee B., Sengupta S. CpG methylation of HPV 16 LCR at E2 binding site proximal to P97 is associated with cervical cancer in presence of intact E2. Virology: 2006; 354 280 285 (Pubitemid 44527961)
50. Ding D. C., Chiang M. H., Lai H. C., Hsiung C. A., Hsieh C. Y., Chu T. Y. Methylation of the long control region of HPV16 is related to the severity of cervical neoplasia. Eur J Obstet Gynecol Reprod Biol: 2009; 147 215 220
51. Jacquin E., Baraquin A., Ramanah R., Carcopino X., Morel A., Valmary-Degano S., Bravo I., de Sanjose S., Riethmuller D., Mougin C., Prétet J. L. Methylation of human papillomavirus type 16 E2BS#1, E2BS#2 and Sp1 binding site CpGs in cervical cancer samples determined by high resolution melting PCR. J Clin Microbiol: 2013; 51 3207 3215
52. Zorko B. A., Pérez L. B., De Blanco E. JC. Effects of ILTG on DAPK1 promoter methylation in colon and leukemia cancer cell lines. Anticancer Res: 2010; 30 3945 3950
53. Orlikova B., Schnekenburger M., Zloh M., Golais F., Diederich M., Tasdemir D. Natural chalcones as dual inhibitors of HDACs and NF- κ B. Oncol Rep: 2012; 28 797 805
54. Nair A., Venkatraman M., Maliekal T. T., Nair B., Karunagaran D. NF-kappaB is constitutively activated in high-grade squamous intraepithelial lesions and squamous cell carcinomas of the human uterine cervix. Oncogene: 2003; 22 50 58 (Pubitemid 36152883)
55. Branca M., Giorgi C., Ciotti M., Santini D., Di Bonito L., Costa S., Benedetto A., Bonifacio D., Di Bonito P., Paba P., Accardi L., Mariani L., Ruutu M., Syrjänen S., Favalli C., Syrjänen K. Upregulation of telomerase (hTERT) is related to the grade of cervical intraepithelial neoplasia, but is not an independent predictor of high-risk human papillomavirus, virus persistence, or disease outcome in cervical cancer. Diagn Cytopathol: 2006; 34 739 748 (Pubitemid 44663249)
56. Xu M., Katzenellenbogen R. A., Grandori C., Galloway D. A. NFX1 plays a role in human papillomavirus type 16 E6 activation of NFkappaB activity. J Virol: 2010; 84 11461 11469
57. Lin Z., Bazzaro M., Wang M. C., Chan K. C., Peng S., Roden R. BS. Combination of proteasome and HDAC inhibitors for uterine cervical cancer treatment. Clin Cancer Res: 2009; 15 570 577
58. Hong-zhi L., Mamat A., Ablise M., Niyaz U., Turdi R. Synthesis and characterisation of isoliquiritigenin derivatives. Chin J New Drugs: 2009; 19 1882 1886
59. Saunier M., Monnier-Benoit S., Mauny F., Dalstein V., Briolat J., Riethmuller D., Kantelip B., Schwarz E., Mougin C., Prétet J. L. Analysis of human papillomavirus type 16 (HPV16) DNA load and physical state for identification of HPV16-infected women with high-grade lesions or cervical carcinoma. J Clin Microbiol: 2008; 46 3678 3685